Primary Bilateral Ovarian Choriocarcinoma in a 33-year-old, G3P3(3003) Female
A Case Report
DOI:
https://doi.org/10.21141/PJP.2025.05Abstract
This is a case of a 33-year-old, G3P3(3003) female patient with a clinical presentation of vaginal bleeding associated with on and off hypogastric pain. The patient was diagnosed and managed as a case of tubo-ovarian abscess and subsequently underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy (TAHBSO). Microscopic sections of both ovaries, however, showed dual population of tumor cells composed of medium-sized, mononucleated cells admixed with multinucleated giant cells with marked pleomorphism, extensive hemorrhage and necrosis. Immunohistochemistry studies using beta-hCG was diagnostic of ovarian choriocarcinoma, favoring non-gestational in origin. Classification of non-gestational choriocarcinoma (NGOC) was established using diagnostic criteria for NGOC established by Saito et al., and Mangla et al. DNA analysis, however, remains to be the gold-standard for differentiating between gestational (GOC) and non-gestational (NGOC) etiology.
Downloads
References
Goldblum JR, Lamps LW, McKenney JK, Myers JL. Choriocarcinoma. In: Rosai and Ackerman’s Surgical Pathology, 11th ed; 2018.
Talerman A, Vang R. Germ Cell Tumors of the Ovary. In: Blaustein’s pathology of the female genital tract. 6th ed. Springer; 2011. DOI: https://doi.org/10.1007/978-1-4419-0489-8_16
Mangla M, Palo S, Kanikaram P, Kaur H. Non-gestational choriocarcinoma: unraveling the similarities and distinctions from its gestational counterpart. Int J Gynecol Cancer. 2024;4(6):926-34. https://pubmed.ncbi.nlm.nih.gov/38123189 https://doi.org/10.1136/ijgc-2023-004906 DOI: https://doi.org/10.1136/ijgc-2023-004906
Magnaeva A, Asaturova A, Tregubova A, Matsneva I, Solopova A. Non-gestational choriocarcinoma of ovary: clinico-morphological features and diagnostic value of DNA polymorphism study. Hum Pathol Rep. 2022;27:000593. https://doi.org/10.1016/j.hpr.2022.300593 DOI: https://doi.org/10.1016/j.hpr.2022.300593
Hayashi S, Abe Y, Tomita S, et al. Primary non-gestational pure choriocarcinoma arising in the ovary: A case report and literature review. Oncol Lett. 2015;9(5):2109-11. https://pubmed.ncbi.nlm.nih.gov/26137022 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467297 https://doi.org/10.3892/ol.2015.2985 DOI: https://doi.org/10.3892/ol.2015.2985
Adow MT, Gebresilasie SF, Abebe NA. Primary ovarian choriocarcinoma: rare entity. Primary ovarian choriocarcinoma: rare entity. Case Rep Obstet Gynecol. 2021;2021:4545375. https://pubmed.ncbi.nlm.nih.gov/34608421 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487380 https://doi.org/10.1155/2021/4545375 DOI: https://doi.org/10.1155/2021/4545375
Cronin S, Ahmed N, Criag AD, et al. Non-gestational ovarian choriocarcinoma: a rare ovarian cancer subtype. Diagnostics (Basel). 2022;12(3):560. https://pubmed.ncbi.nlm.nih.gov/35328112 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947355 https://doi.org/10.3390/diagnostics12030560 DOI: https://doi.org/10.3390/diagnostics12030560
Euscher ED, Liu A, Rabban JT. Non-gestational choriocarcinoma. In: WHO Classification of Tumours Editorial Board, ed. WHO classification of tumours: female genital tumours. 5th ed. Vol 4. International Agency for Research on Cancer; 2020.
Chongco- Angeles UL, Tolentino, A, Gaddi A. Non-gestational ovarian choriocarcinoma: a rare encounter. Philipp J Obstet Gynecol. 2001;25(1):22-8.
Mood NI, Samadi N, Rahimi-Moghaddam P, Sarmadi S, Eftekhar Z, Yarandi F. Pure ovarian choriocarcinoma: report of two cases. J Res Med Sci. 2009;14(5):327-30. https://pubmed.ncbi.nlm.nih.gov/21772904 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129104
Ali TZ, Parwani AV. Current concepts in genitourinary pathology: kidney and testes. Surg Pathol Clin. 2009;2(1):61-159. https://doi.org/10.1016/j.path.2008.08.007 DOI: https://doi.org/10.1016/j.path.2008.08.007
Gilks B. Ovary. In: Goldblum JR, Lamps LW, McKenney JK, Myers JL, eds. Rosai and Ackerman’s Surgical Pathology. 11th ed. Elsevier; 2018.
Zhong Y, Chen X, Huang Y, et al. Ovarian high-grade serous carcinoma with elevated β-human chorionic gonadotropin. Medicine (Baltimore). 2021;100(51):e28144. https://pubmed.ncbi.nlm.nih.gov/34941061 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702252 https://doi.org/10.1097/MD.0000000000028144 DOI: https://doi.org/10.1097/MD.0000000000028144
Edmund LN, Salama AM, Murali R. Cytologic features of sex cord-stromal tumors in women. Cancer Cytopathol. 2022;130(1):55-71. https://pubmed.ncbi.nlm.nih.gov/34411449 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439705 https://doi.org/10.1002/cncy.22502 DOI: https://doi.org/10.1002/cncy.22502
Miettinen M, Wang Z, McCue PA, et al. SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases. Am J Surg Pathol. 2014;38(3):410-20. Phttps://pubmed.ncbi.nlm.nih.gov/24525512 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041084 https://doi.org/10.1097/PAS.0000000000000116 DOI: https://doi.org/10.1097/PAS.0000000000000116
Lan L, Luo Y, Zhou M, et al. Comparison of diagnostic accuracy of thyroid cancer with ultrasound-guided fine-needle aspiration and core-needle biopsy: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2020;11:44. https://pubmed.ncbi.nlm.nih.gov/32117069 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033392 https://doi.org/10.3389/fendo.2020.00044 DOI: https://doi.org/10.3389/fendo.2020.00044
Saito M, Azuma T, Nakamura K. On ectopic choriocarcinoma. World Obstet Gynecol. 1963;17:459–84.
Rabban J, Euscher E, Liu A. Non gestational choriocarcinoma. In: WHO Classification of Tumours: Female Genital Tumours. 5th ed, Vol 4. Lyon, France: International Agency for Research on Cancer; 2020.
Cheung ANY, Shen DH, Khoo US, Wong LC, Ngan HYS. p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression. J Clin Pathol. 1998;51(2):159–62. https://pubmed.ncbi.nlm.nih.gov/9602692 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC500513 https://doi.org/10.1136/jcp.51.2.159 DOI: https://doi.org/10.1136/jcp.51.2.159
Sui MKY, Wong ESY, Chan HY, Ngan HYS, Chan KYK, Cheung ANY. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am J Pathol. 2008;173(4):1165-72. https://pubmed.ncbi.nlm.nih.gov/18772339 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2543083 https://doi.org/10.2353/ajpath.2008.080288 DOI: https://doi.org/10.2353/ajpath.2008.080288
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Sarah Lizette Aquino-Cafino, Jose Vicente Borja II, Al-Zamzam Abubakar

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.









@philippinepathologyjournal